Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Boston's InSpire MD Eyes $24.8 Million Series C Round January 25, 2017 Juno Finally Drops Problem CAR-T Drug That Caused Deaths March 1, 2017 How Immigration Ban is Already Hurting Science January 29, 2017